779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
oleh: Aung Naing, Emiliano Calvo, Chen Zhu, Martin Gutierrez, Elena Garralda, Giovanni Abbadessa, Helene Guillemin-Paveau, Meijing Wu, Raymond Perez, Marloes van Dongen, Ferry Eskens, Morgan Finlay, Fatima Menas, Ozlem Yildirim
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.